ArticleJournal of pharmaceutical policy and practice2019

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Rumiko Shimazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.